Navigation Links
Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc.
Date:1/15/2014

companies and could cause actual results to differ materially from those expressed in forward-looking statements contained in this press release. These factors include, but are not limited to: the risk that the acquisition will not close when expected or at all; the risk that Valeant's business and/or Solta's business will be adversely impacted during the pendency of the acquisition; the risk that the operations of the two companies will not be integrated successfully; and other risks and uncertainties, including those detailed from time to time in the companies' periodic reports filed with the Securities and Exchange Commission ("SEC") and in the case of Valeant, the Canadian Securities Administrators ("CSA"), including current reports on Form 8-K, quarterly reports on Form 10-Q and annual reports on Form 10-K, which have been filed with the SEC and in the case of Valeant, the CSA.  The forward-looking statements in this press release are qualified by these risk factors. The companies assume no obligation to publicly update any forward-looking statements, whether as a result of new information, future developments or otherwise.

Additional Information and Where to Find It

This press release is neither an offer to purchase nor a solicitation of an offer to sell shares of Solta. Valeant filed a Tender Offer Statement on Schedule TO with the SEC on December 23, 2013. Solta filed a Solicitation/Recommendation Statement on Schedule 14D-9 with respect to the offer on December 23, 2013.   Stockholders of Solta are urged to read the tender offer materials (including the Offer to Purchase, a related Letter of Transmittal and certain other offer documents) and the Solicitation/Recommendation Statement, in each case as amended (to the extent applicable), because they contain important information which should be read carefully before any decision is made with respect to the tender offer. The Offer to Purchase, the related Letter of Transmittal and
'/>"/>

SOURCE Valeant Pharmaceuticals International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Presentation Schedules, Stock Movements, Agreements, and New Appointments - Research Report on Celgene, Merck, Bristol-Myers, Valeant, and Mylan
2. Valeant Pharmaceuticals To Present At Industry Conferences
3. Valeant Pharmaceuticals Agrees to Acquire Solta Medical for $2.92 Per Share in Cash
4. Valeant Pharmaceuticals Announces Redemption Of The Remaining $465.5 Million Aggrerate Principal Amount Of Its Outstanding 6.50% Senior Notes Due 2016
5. Valeant Pharmaceuticals Announces Pricing Of Private Offering Of Senior Notes
6. Valeant Pharmaceuticals Announced Redemption Of $450 Million Aggregate Principal Amount Of Its Outstanding 6.50% Senior Notes Due 2016
7. Valeant Pharmaceuticals Reports 2013 Third Quarter Financial Results
8. Valeant Pharmaceuticals Announces Settlement Agreement With Anacor
9. Valeant Pharmaceuticals Announces Partnership With National Coalition Against Domestic Violence
10. Valeant Pharmaceuticals Announces Continuance
11. Valeant Pharmaceuticals Reports 2013 Second Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... SAN DIEGO , July 29, 2015  ViaCyte, Inc., a ... therapy for the treatment of diabetes in clinical trials, today announced ... called STEP ONE, or S afety, T olerability, and ... One Diabetes.  The new site, which is the first ... of Alberta Hospitals in Edmonton , Alberta.  ...
(Date:7/29/2015)... -- Fifty groups representing 500,000 patients, doctors, and researchers will ... AllTrials campaign in the US. The global campaign calls ... be registered and the results from it reported. ... explains: "Patients want the treatments that are best for ... Unfortunately, we now know that around half of all ...
(Date:7/29/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/hmjqff/global_wound_care ... "Global Wound Care Markets (Twelve Country Analysis: Germany, ... China, India, Brazil, Australia, South Korea)" report ... provides a competitive market summary. The wound care ... offerings and product maturity. Several of the products ...
Breaking Medicine Technology:ViaCyte Announces Second Clinical Trial Site at University of Alberta 2ViaCyte Announces Second Clinical Trial Site at University of Alberta 3ViaCyte Announces Second Clinical Trial Site at University of Alberta 4Fixing Your Medicine: AllTrials Campaign Launches in US 2Fixing Your Medicine: AllTrials Campaign Launches in US 3Global Wound Care Markets 2015 2
(Date:7/29/2015)... ... July 29, 2015 , ... Today marks a significant achievement ... in women-led, growth companies and is led by a group of experienced investors, has ... and voted with their dollars to be a part of the fund. The ...
(Date:7/29/2015)... , ... July 29, 2015 , ... CanAm Enterprises, LLC ... USCIS over the past month! I-829 approvals have been granted to investors in four ... Angeles, the Kimpton Lafayette Hotel project in Philadelphia, and the Valley Forge Convention Center ...
(Date:7/29/2015)... Angeles, CA (PRWEB) , ... July 29, 2015 ... ... to Honduras with the Hackett Hemwall Foundation in March, Steven W. Meier M.D., ... pro bono prolotherapy treatments to qualifying patients with demonstrated financial need. , “We ...
(Date:7/29/2015)... ... , ... Employee Fiduciary, LLC announces the launch of its new, online Financial ... plans administered, years in business, and credentials of all Employee Fiduciary financial advisor ... Employee Fiduciary. A search can be done by zip code so a plan sponsor ...
(Date:7/29/2015)... ... 2015 , ... TransFlip is an all new dynamic transition pack for FCPX, ... these transitions are easy to apply and modify for any skill-level user. TransFlip includes ... preset styles, kinetic flipping panel animations are just a few clicks away. , TransFlip ...
Breaking Medicine News(10 mins):Health News:Sofia Fund Surpasses Investor Goals 2Health News:More Than 60 New I-829 Approvals in Less Than 30 days for CanAm 2Health News:More Than 60 New I-829 Approvals in Less Than 30 days for CanAm 3Health News:Orthopedic Surgeon Announces New Pro Bono Prolotherapy and Regenerative Medicine Clinic for Underserved Communities in Los Angeles 2Health News:Employee Fiduciary Launches Financial Advisor Directory 2Health News:Pixel Film Studios Releases FCPX Transition TransFlip for FCPX 2
... ... effective in aiding weight loss. Users say it helps them lose up to 40 ... ... of "super chocolate" has been fast increasing popularity among international models and athletes as ...
... (embargo: 6 May, 16:45 CEST) , J. Hicks, USA, ... from very small samples , Researchers have developed a powerful ... The breakthrough allows them to study in fine detail the ... receptor status of HER2+ breast cancer correlates with response to ...
... of Pediatrics, Global Health and Epidemiology & Biostatistics ... has been selected by the J. William Fulbright ... Fulbright Scholarship. Beginning in August 2010, Dr. Mandalakas ... in collaboration with Stellenbosch University to study the ...
... ... ... CosmoCom the global leader in Contact Center Consolidation 2.0, announced that its healthcare contact ... (LISA). Presented by the Long Island Software and Technology Network (LISTnet), the LISA recognizes ...
... ... ... for the Skinny on Willpower! The publishing industry is in the midst of a revolutionary change, ... The Skinny On series. The series, recent hit, The Skinny On Willpower , addresses ...
... Urns.com Offers New Biodegradable Urns ... More Give People The Option To Have More A Eco-Friendly Funeral. , ... Goleta, CA (PRWEB) May 6, 2010 –- When a loved one ... where those left behind need to consider not only the wishes of the deceased, but also ...
Cached Medicine News:Health News:Super Fat-Melting Chocolate Recipe Revealed 2Health News:Super Fat-Melting Chocolate Recipe Revealed 3Health News:IMPAKT Breast Cancer Conference press program 2Health News:CWRU global TB expert receives prestigious Fulbright Scholar Award 2Health News:CWRU global TB expert receives prestigious Fulbright Scholar Award 3Health News:CosmoCom Wins Software Award for CosmoHealth 2Health News:CosmoCom Wins Software Award for CosmoHealth 3Health News:Readers and Reviewers Rave about 'The Skinny On Willpower' 2Health News:Readers and Reviewers Rave about 'The Skinny On Willpower' 3Health News:Readers and Reviewers Rave about 'The Skinny On Willpower' 4Health News:Urns.com Announces Urns As An Eco Friendly Burial Alternative 2
For vacuum-driven processing of spin columns; Reduced sample handling and accelerated processing; Parallel sample processing using QIAGEN spin columns; Easy cleaning of internal components by simpl...
Inquire...
... The Perfect Single Vac ... one 96-well plate in 30 ... with an "open/closed" switch and ... for easy operation. contains vacuum ...
... has been designed for use with Bioneer's ... can handle 96 samples (Plasmid DNA, Genomic ... and purification. While conventional kits use centrifugal ... BioVac 96 Vacuum Manifold uses vacuum pressure ...
Medicine Products: